SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-060234
Filing Date
2022-12-07
Accepted
2022-12-07 18:20:23
Documents
1
Period of Report
2022-12-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4305
  Complete submission text file 0001209191-22-060234.txt   5692
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Issuer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TWO CARLSON PARKWAY, SUITE 260 MINNEAPOLIS MN 55447
Business Address
Burroughs Amy L. (Reporting) CIK: 0001872564 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40656 | Film No.: 221451050